Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP331871.RAKre3BPiOvhsyEzo2td5WIsZv1N3szHfl_ENzHjfVhyg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331871.RAKre3BPiOvhsyEzo2td5WIsZv1N3szHfl_ENzHjfVhyg130_assertion type Assertion NP331871.RAKre3BPiOvhsyEzo2td5WIsZv1N3szHfl_ENzHjfVhyg130_head.
- NP331871.RAKre3BPiOvhsyEzo2td5WIsZv1N3szHfl_ENzHjfVhyg130_assertion description "[RASSF1A and RASSF1B transcripts were not expressed in 60% (9 of 15) and 33% (5 of 15) of gastric carcinoma cell lines, respectively, whereas RASSF1C was detectable in all cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331871.RAKre3BPiOvhsyEzo2td5WIsZv1N3szHfl_ENzHjfVhyg130_provenance.
- NP331871.RAKre3BPiOvhsyEzo2td5WIsZv1N3szHfl_ENzHjfVhyg130_assertion evidence source_evidence_literature NP331871.RAKre3BPiOvhsyEzo2td5WIsZv1N3szHfl_ENzHjfVhyg130_provenance.
- NP331871.RAKre3BPiOvhsyEzo2td5WIsZv1N3szHfl_ENzHjfVhyg130_assertion SIO_000772 11585730 NP331871.RAKre3BPiOvhsyEzo2td5WIsZv1N3szHfl_ENzHjfVhyg130_provenance.
- NP331871.RAKre3BPiOvhsyEzo2td5WIsZv1N3szHfl_ENzHjfVhyg130_assertion wasDerivedFrom befree-2016 NP331871.RAKre3BPiOvhsyEzo2td5WIsZv1N3szHfl_ENzHjfVhyg130_provenance.
- NP331871.RAKre3BPiOvhsyEzo2td5WIsZv1N3szHfl_ENzHjfVhyg130_assertion wasGeneratedBy ECO_0000203 NP331871.RAKre3BPiOvhsyEzo2td5WIsZv1N3szHfl_ENzHjfVhyg130_provenance.